Melanoma patients at UCSF receive the highest level of care available with standard therapy and state-of-the-art technologies. Yet our commitment to eradicating melanoma is also fueled by a passion for scientific investigation and discovery that significantly improves that standard-of-care.
Beyond conventional therapies, patients have access to investigational therapies for melanoma. UCSF offers melanoma patients a broad menu of clinical trials, providing those eligible with access to some of the most promising novel agents and targeted therapies.
Our clinical trials span various stages of melanoma, and include disease prevention, recurrence in high-risk surgical patients, and innovative drug therapies for patients with advanced metastatic melanoma.
Our principal investigators collaborate with melanoma
researchers world-wide including the National Cancer Institute
(NCI), cooperative inter-institutional research groups such as
CALGB, ECOG, SWOG, ACSOG, and RTOG, and pharmaceutical companies to
conduct clinical trials for the most promising therapies in